A Pediatric Case of Sirolimus-Associated Pneumonitis After Kidney Transplantation
نویسندگان
چکیده
منابع مشابه
Sirolimus after kidney transplantation.
The risk of cancer is increased after kidney transplantation and is predominantly attributed to oncogenic immunosuppression. It is a leading cause of death for kidney allograft recipients, and analyses of transplant registry data suggest that mortality related to cancer is on the increase. Strategies to reduce the risk of cancer bymodifying immunosuppression are therefore desirable but must be ...
متن کاملPediatric kidney transplantation: An overview
Kidney Transplantation in children is the treatment of choice to treat end stage renal disease. Improvements in immunosuppressive management have dramatically reduced the risk of early acute rejection and graft loss, however the long term results in terms of graft survival and morbidity still require search for new immunosuppressive regimens. Reducing of side effects are the challenges for impr...
متن کاملNINE CASES OF MALIGNANCY AFTER KIDNEY TRANSPLANTATION
Renal transplantation is considered one of the best long-term therapies for chronic renal failure, but unfortunately the incidence of malignancy significantly increases in renal transplant recipients. We analyzed nine cases of malignancy in 200 renal transplant recipients occurring in a 12-year follow-up in Imam hospital of Tehran University, Tehran, Iran. According to this study, the organ...
متن کاملUnusual radiological presentation of sirolimus-associated pneumonitis.
Sirolimus-associated pneumonitis, a rare but serious drug-induced lung injury, has become a great concern clinically, because of the increasing use of sirolimus (rapamycin) in patients who have been subjected to solid organ transplantation. We report sirolimus-associated pneumonitis in two women who underwent renal transplantation. At variance with previous reports, the radiological findings sh...
متن کاملtreatment of an early kaposi’s sarcoma case post kidney transplantation by sirolimus: a case report
kaposi᾽s sarcoma (ks) can develop in 0.06% to 4.1% of kidney transplant recipients. here we describe a case of 50-year-old man who developed ks a few months after kidney transplantation . after transplantation, he had delayed graft function and was managed by anti-thymocyte globulin (atg) for five days. at the discharge, his immunosuppressive therapy was prednisolone 20 mg/day, ttacrolimus (ppr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Pediatric Pharmacology and Therapeutics
سال: 2020
ISSN: 1551-6776
DOI: 10.5863/1551-6776-25.5.459